Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
DBCAT004033Pharmacologic class
A DrugBank category of 27 drugs. 27 of them are approved.
What you can answer from here — as of September 19, 2019
Which targets do Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account